Literature DB >> 35487789

Risk Factors for Silent Brain Infarcts and White Matter Disease in a Real-World Cohort Identified by Natural Language Processing.

Lester Y Leung1, Yichen Zhou2, Sunyang Fu3, Chengyi Zheng2, Patrick H Luetmer4, David F Kallmes4, Hongfang Liu3, Wansu Chen2, David M Kent5.   

Abstract

OBJECTIVE: To assess the frequency of silent brain infarcts (SBIs) and white matter disease (WMD) and associations with stroke risk factors (RFs) in a real-world population. PATIENTS AND METHODS: This was an observational study of patients 50 years or older in the Kaiser Permanente Southern California health system from January 1, 2009, through June 30, 2019, with head computed tomography or magnetic resonance imaging for nonstroke indications and no history of stroke, transient ischemic attack, or dementia. A natural language processing (NLP) algorithm was applied to the electronic health record to identify individuals with reported SBIs or WMD. Multivariable Poisson regression estimated risk ratios of demographic characteristics, RFs, and scan modality on the presence of SBIs or WMD.
RESULTS: Among 262,875 individuals, the NLP identified 13,154 (5.0%) with SBIs and 78,330 (29.8%) with WMD. Stroke RFs were highly prevalent. Advanced age was strongly associated with increased risk of SBIs (adjusted relative risks [aRRs], 1.90, 3.23, and 4.72 for those aged in their 60s, 70s, and ≥80s compared with those in their 50s) and increased risk of WMD (aRRs, 1.79, 3.02, and 4.53 for those aged in their 60s, 70s, and ≥80s compared with those in their 50s). Magnetic resonance imaging was associated with a reduced risk of SBIs (aRR, 0.87; 95% CI, 0.83 to 0.91) and an increased risk of WMD (aRR, 2.86; 95% CI, 2.83 to 2.90). Stroke RFs had modest associations with increased risk of SBIs or WMD.
CONCLUSION: An NLP algorithm can identify a large cohort of patients with incidentally discovered SBIs and WMD. Advanced age is strongly associated with incidentally discovered SBIs and WMD.
Copyright © 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35487789      PMCID: PMC9284412          DOI: 10.1016/j.mayocp.2021.11.038

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   11.104


  17 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Authors:  Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Blood Pressure and Heart Rate Measures Associated With Increased Risk of Covert Brain Infarction and Worsening Leukoaraiosis in Older Adults.

Authors:  Lester Y Leung; Traci M Bartz; Kenneth Rice; James Floyd; Bruce Psaty; Jose Gutierrez; W T Longstreth; Kenneth J Mukamal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-29       Impact factor: 8.311

4.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study.

Authors:  D Liao; L Cooper; J Cai; J F Toole; N R Bryan; R G Hutchinson; H A Tyroler
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

5.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

6.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

7.  Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study.

Authors:  Paul Muntner; Jeff Whittle; Amy I Lynch; Lisandro D Colantonio; Lara M Simpson; Paula T Einhorn; Emily B Levitan; Paul K Whelton; William C Cushman; Gail T Louis; Barry R Davis; Suzanne Oparil
Journal:  Ann Intern Med       Date:  2015-09-01       Impact factor: 25.391

8.  Agreement between neuroimages and reports for natural language processing-based detection of silent brain infarcts and white matter disease.

Authors:  Lester Y Leung; Sunyang Fu; Patrick H Luetmer; David F Kallmes; Neel Madan; Gene Weinstein; Vance T Lehman; Charlotte H Rydberg; Jason Nelson; Hongfang Liu; David M Kent
Journal:  BMC Neurol       Date:  2021-05-11       Impact factor: 2.474

9.  Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.

Authors:  Lester Y Leung; Paul K J Han; Christine Lundquist; Gene Weinstein; David E Thaler; David M Kent
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

10.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.